SUDEEPPHRM

Sudeep Pharma Limited

Source: NSE · Updated 4 Nov, 11:32 pm IST

Filed 28 Oct, 07:14 pm IST Q2 FY27 (Sep ’26)Consolidated₹ lakhs

Revenue

19,669.91

▲ 20.9% vs Q2 FY26

Operating profit (EBITDA, derived from filing)

7,323.74

▲ 32.1% vs Q2 FY26

Net profit

5,181.11

▲ 10.8% vs Q2 FY26

EPS (₹)

4.59

▲ 9.3% vs Q2 FY26

Operating margin

37.2%

+310 bps vs Q2 FY26

Net margin

26.3%

−250 bps vs Q2 FY26

Revenue up, profit up vs Q2 FY26

Revenue+21% vs Q2 FY26 · +24% vs Q1 FY27

Profit+11% vs Q2 FY26 · +28% vs Q1 FY27

View official filing ↗

Numbers from the company's structured XBRL filing on NSE, cross-checked with P&L totals.

Previous-quarter and year-ago figures: as originally reported in those quarters' NSE filings; filing PDF not available to confirm restatements.

Quarter comparison

Item	Q2 FY27 (Sep ’26)	Q1 FY27 (Jun ’26)	vs Q1 FY27	Q2 FY26 (Sep ’25)	vs Q2 FY26
Revenue from operations	19,669.91	15,827.05	▲ 24.3%	16,266.62	▲ 20.9%
Other income	598.43	544.54	▲ 9.9%	1,016.55	▼ 41.1%
Total income	20,268.34	16,371.59	▲ 23.8%	17,283.17	▲ 17.3%
Total expenses	13,165.09	10,942.33	▲ 20.3%	11,329.8	▲ 16.2%
Operating profit (EBITDA)*	7,323.74	5,491.13	▲ 33.4%	5,546.15	▲ 32.1%
Profit before tax	7,103.25	5,429.26	▲ 30.8%	5,953.37	▲ 19.3%
Tax expense	1,922.14	1,370.57	▲ 40.2%	1,275.55	▲ 50.7%
Net profit	5,181.11	4,058.69	▲ 27.7%	4,677.82	▲ 10.8%
EPS (₹)	4.59	3.59	▲ 27.9%	4.20	▲ 9.3%
Operating margin	37.2%	34.7%	+250 bps	34.1%	+310 bps
Net margin	26.3%	25.6%	+70 bps	28.8%	−250 bps

Showing Q2 FY27 (Sep ’26) and change vs Q2 FY26. Turn your phone sideways for Q1 FY27 (Jun ’26).

Figures in ₹ lakhs except EPS. Consolidated figures from the company's XBRL filing on NSE. Each row is shown only if it reconciles with the others (e.g. PBT − tax = net profit); rows we couldn't verify are left out. Net margin = net profit ÷ revenue. *Operating profit (EBITDA), derived from the filing: profit before exceptional items and tax + finance costs + depreciation − other income. Operating margin = EBITDA ÷ revenue.

All Sudeep Pharma results, dividends & filings ›

Other results filed 28 Oct

ORBTEXP Orbit Exports Limited›GMRAIRPORT GMR AIRPORTS LIMITED›CHOLAFIN Cholamandalam Investment and Finance Company Limited›MOSCHIP Moschip Technologies Limited›ONMOBILE OnMobile Global Limited›INFOBEAN InfoBeans Technologies Limited›DODLA Dodla Dairy Limited›BOROSCI Borosil Scientific Limited›ZENSARTECH Zensar Technologies Limited›GRPLTD GRP Limited›ADANIENT Adani Enterprises Limited›CNL Creative Newtech Limited›

Today's results ›

SUDEEP PHARMA Q2 FY27 ; NET PROFIT UP 11% AT ₹52 CR (YOY), UP 28% (QOQ)

REVENUE UP 21% AT ₹197 CR (YOY), UP 24% (QOQ)

EBITDA UP 32% AT ₹73 CR (YOY), UP 33% (QOQ)

MARGINS AT 37.2% VS 34.1% (YOY), 34.7% (QOQ)

https://resultkal.com/r/sudeepphrm-2026-10-28
Source: NSE filing · not investment advice

FAQ

When did Sudeep Pharma announce Q2 FY27 results?

Sudeep Pharma filed its results on NSE on 28 Oct, 07:14 pm IST.

What does QoQ and YoY mean?

QoQ compares with the previous quarter; YoY compares with the same quarter last year. Growth is calculated from the figures in the filing.

Are these Sudeep Pharma figures official?

They are auto-read from the company's NSE filing and may contain errors. Always confirm with the official PDF linked on this page.

Explore

Today's results Results this week Q2 FY27 results dates Dividend stocks this week Bonus issue 2026 Stock split 2026

Figures are auto-read from the company's NSE filing and may contain errors. Check the official filing before deciding. Not investment advice.

← SUDEEPPHRM overview